Resources

55 Resources for

management and pharmaceutical company

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Business Dictionary

Management
the use of professional skills for identifying and achieving organizational objectives through the deployment of appropriate resources. Management involves identifying what needs to be done, and organizing and supporting others...
Management definition on BNET »

BNET Resources

Corporate Credibility: Healing the Faith
Business risks have reached their highest level in several decades due to upheavals in the business environment. But the control-oriented risk management systems that served pharmaceuticals well in the past are no longer adequate. Risks are now streaming in from many new directions. There is no doubt that the woes...
Tags: PricewaterhouseCoopers Consulting, Pharmaceutical Company, Risk Management, Risks, Financial Planning, Strategy, Financial Services, Security, Finance, Management
White papers 2003-08-12
Beyond the Blockbuster : Finding the Next Profit zone in Pharmaceuticals Through Business Design Thinking
The rapid growth of pharma companies in the 1990s was driven by a ‘blockbuster' model. This model is under pressure: Slowing scientific innovation and rising development costs combine with prescribers, payors and patients becoming tougher customers. But investor expectations remain high as much of the value of companies is still...
Tags: Blockbuster Inc., Pharmaceutical Company, Blockbuster, Marsh & McLennan Companies, Strategy, Management
White papers 2003-01-01
Healthcare, Pharmaceutical And Biotech Resilient Amid Job Market Woes
On the one hand where most industries were badly hit by the aftermath of September 11 incidents, there were few exceptions also. The industries such as healthcare, pharmaceutical, and biotech remained flexible despite job market's affliction. The paper elaborates on how the exceptional industries remained untouched by the suffering economy....
Tags: Biotechnology, Enterprise Software, Health Care, Job, Management, Medzilla, Pharmaceutical Company, Software, Strategy, Vertical Industries
White papers 2003-01-01
Regulating The Outsource Provider
From the executive summary: ‘Excellence is never cheap, because it stems from a sound approach, experience, and time-intensive work. The cost to a product development program for truly outstanding consultation is worth avoiding the risk of failed clinical trial, major regulatory errors or even the loss of a small amount...
Tags: Excellence, Outsource, Pharmaceutical Company, Product Development, Outsourcing, Product Marketing, Strategy, Research & Development, Business Operations, It Operations, Outsourcing & Subcontracting, Marketing, Management
White papers 2003-01-01
The Formula For Outsourcing Success
Good project management at all levels of the organization results from effective communication and teamwork between the client and contractor. The appointment of an ombudsman by the client and the contractor culminates into an effective project management. Four factors are responsible for successful partnership between the client and the contractor....
Tags: Contractor, Pharmaceutical Company, Project Management, Tools & Techniques, Outsourcing, Strategy, It Operations, It service Management, Management, Business Operations, Outsourcing & Subcontracting
White papers 2003-01-01
Outlook: Potential and Pitfalls in Pharmaceuticals
There are potentially massive profits to be made in the pharmaceuticals' industry, if it can overcome the massive challenges posed by regulation, financing, and globalization, according to executives and venture capitalists. This has been outlined in this paper. It is also agreed that mapping the human genome has created great...
Tags: Microsoft Outlook, President, Harvard College, Pharmaceutical Company, Globalization, Biotechnology, Venture Capital, Strategy, Management, Finance, Financing Startups
White papers 2003-04-16
People - The Key to Optimizing the Pipeline
The challenges currently facing the pharmaceutical industry are myriad. Whether it is the failure to meet R & D productivity goals, the scarcity of talent, changing demographics and skills requirements, or the advance of individualized medicine, it will be people, the industry's primary asset, who will shape the response to...
Tags: PricewaterhouseCoopers Consulting, Pharmaceutical Company, Research & Development, Strategy, Business Operations, Management
White papers 2003-09-24
Industry Insight: New Environment
Protecting intellectual property is paramount in the pharmaceutical industry. The new rules require that companies disclose their reasons for doing a deal and paying a premium over book value. Because this is sensitive data in a consolidating industry, companies and their advisers must develop best practices for complying with these...
Tags: Accounting, Environment, Management, Pharmaceutical Company, PricewaterhouseCoopers Consulting, Strategy
White papers
Health Care Distribution and Service Companies: Reflections on a Changing Business Model
The pharmaceutical distribution sector is undergoing a change in the very structure of its core business model, shifting from a traditional "buy-and-hold" model to a fee-for-service model that is more akin to just-in-time inventory. Under the current traditional business model, distributors, to varying degrees, make a portion of their margin...
Tags: Price Increase, Pharmaceutical Company, Business Model, Health Care, JIT, Fitch, Quality, Strategy, Business Operations, Management
White papers 2004-05-05
The Human and Economic Value of Pharmaceutical Innovation and Opportunities for the NHS
Innovation is vital in the health care system. Innovation can be about improving compliance with existing treatment regimes, bringing new ways of treating patients, providing their treatment more cost effectively, or expanding the boundaries of what can be treated. Innovation can come in many forms new medicines, different devices, improved...
Tags: Innovation, Pharmaceutical Company, Health Care, Leadership, Strategy, Vertical Industries, Benefits, Management, Enterprise Software, Software, Human Resources
White papers 2004-05-07
Code of Practice for the Pharmaceutical Industry 2003
The paper informs that investment into researching and developing new products in the UK is now running at around ·3.2 billion a year and each new medicine takes an average of ten to twelve years to develop before it is authorized for use by doctors, with no guarantee of commercial...
Tags: Management, Pharmaceutical Company, Strategy
White papers 2004-08-09
Ethical Issues Concerning the Relationships Between Medical Practitioners and the Pharmaceutical Industry
The paper shows that relationships involving medical practitioners and the pharmaceutical industry raise serious concerns and controversy within both the medical profession and the broader community. Within the profession itself views differ sharply, from the conviction that the risks associated with such relationships are minimal to a concern that all...
Tags: Management, Pharmaceutical Company, Practitioner, Relationship, Strategy, University Of North Dakota
White papers 2002-02-04
A Healthy Regimen for Pharmaceuticals
The paper outlines that to succeed, companies need new competencies and capabilities, and they have to excel at them. The industry needs an aggressive, yet workable, plan to deliver the growth investors expect in this challenging environment. Pharma companies need to focus on three important steps: get big, get flexible...
Tags: A.T. Kearney, Management, Pharmaceutical Company, Strategy
White papers 2004-04-28
The Influence of the Pharmaceutical Industry
The interests of pharmaceutical companies and those of the public, patients and the NHS often overlap but they are not identical. For the industry, medical need must be combined with the likelihood of a reasonable return on investment. An effective regulatory regime to ensure that the industry works in the...
Tags: Management, Pharmaceutical Company, Strategy
White papers 2005-03-22
Solving Information Problems in the Pharmaceutical Industry
Drug development is an information-intensive process. Identifying diseases, target compounds, and target markets is only the beginning of an often 15-year road to drug approval. Some of the challenges facing the pharmaceutical industry include: Extracting knowledge from diverse sources to predict pharmacological and toxicological effects; these sources include physical properties...
Tags: Knowledge, Management, Pharmaceutical Company, Strategy, Verity Inc.
White papers 2002-09-27
Innovation and Market Structure in the Dynamics of the Pharmaceutical Industry and Biotechnology: Towards a History-Friendly Model
This paper is a first attempt at modeling the long-term dynamics of market structure and innovation in the pharmaceutical industry in a history-friendly way. The model examines the relationships between the nature of the search space, demand, the patterns of competition, and industry evolution in the age of random screening...
Tags: Biotechnology, Innovation, Management, Open University, Pharmaceutical Company, Strategy
White papers 2002-06-14
SAP for Life Sciences in the Pharmaceutical Industry
The life sciences industry is dynamic - always innovating, always in flux. What worked yesterday might not work today. That's why pharmaceutical, biotechnology, and medical device companies are constantly seeking better ways to manage complexity, comply with regulations, cut costs, and boost productivity. In pursuit of these objectives, life sciences...
Tags: Healthcare, Life Science, Life Sciences Industry, Management, Pharmaceutical Company, SAP AG, Strategy
White papers 2003-12-02
Innovative Sourcing Strategies
The efficient allocation of capital, particularly in the "make or buy" decision, has the power to increase earnings and shareholder value. The state of the pharmaceutical industry makes strategic sourcing decisions more important and more urgent than ever. What are the benefits and possible problems inherent in sourcing, and what...
Tags: Sourcing, Johnson & Johnson, Pharmaceutical Company, Allocation, Strategic Sourcing, Purchasing & Procurement, Strategy, Business Operations, Management
White papers 2001-05-11
Patents, Innovation and Access to New Pharmaceuticals
This paper considers the role of intellectual property rights in the development of and access to new pharmaceuticals. A number of studies have found patents are significantly more important to pharmaceutical firms in appropriating the benefits from innovation compared to other high tech industries. The reason for this is because...
Tags: Innovation, Patent, Microsoft Access, Pharmaceutical Company, Duke University, Leadership, Intellectual Property, Strategy, Management, Research & Development, Business Operations
White papers 2002-07-01
Recapturing the Vision: Integrity Driven Performance in the Pharmaceutical Industry
Over the last few years, pharmaceutical companies have seen an increasing level of regulatory scrutiny and highly critical media coverage of the industry's R&D, marketing and manufacturing practices. As a result, there has been a noticeable decline in consumer and investor confidence and a growing degree of negative perceptions about...
Tags: Management, Performance, Pharmaceutical Company, PricewaterhouseCoopers Consulting, Strategy, Vision
White papers 2005-06-29
advertisement
advertisement
Click Here